{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:47:38Z","timestamp":1787064458143,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.clineuro.2019.105587","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:36:11Z","timestamp":1572867371000},"page":"105587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Plasma homocysteine, folate and vitamin B12 levels in Parkinson\u2019s disease in China: A meta-analysis"],"prefix":"10.1016","volume":"188","author":[{"given":"Bao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-4543","authenticated-orcid":false,"given":"Rongrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2019.105587_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"9459","key":"10.1016\/j.clineuro.2019.105587_bib0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(05)70801-1","article-title":"Parkinson\u2019s disease in China: prevalence in Beijing, Xian, and Shanghai","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clineuro.2019.105587_bib0015","first-page":"267","article-title":"Parkinson disease: an update","volume":"87","author":"Gazewood","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2019.105587_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jns.2007.08.015","article-title":"Management of non-motor symptoms in advanced Parkinson disease","volume":"266","author":"Truong","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.clineuro.2019.105587_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189682","article-title":"Factors influencing psychological well-being in patients with Parkinson\u2019s disease","volume":"12","author":"Nicoletti","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.archger.2013.04.015","article-title":"Clinical significance of homocysteine (hcy) on dementia in Parkinson\u2019s disease (PD)","volume":"57","author":"Song","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/fcp.12145","article-title":"Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression","volume":"29","author":"Bhatia","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"14","key":"10.1016\/j.clineuro.2019.105587_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","author":"Ganguly","year":"2015","journal-title":"Nutr. J."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0045","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jn\/136.6.1731S","article-title":"The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease","volume":"136","author":"Refsum","year":"2006","journal-title":"Nutr. J."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jamapsychiatry.2016.0274","article-title":"Association of vitamin B12, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: a longitudinal population-based study","volume":"73","author":"Hooshmand","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.clineuro.2019.105587_bib0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2006-9404","article-title":"Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer\u2019s disease?","volume":"9","author":"Seshadri","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.clineuro.2019.105587_bib0060","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/clinchem\/44.8.1833","article-title":"Homocysteine and vitamins in cardiovascular disease","volume":"44","author":"Jacobsen","year":"1998","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0065","first-page":"450","article-title":"Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in Parkinson disease","volume":"20","author":"Fu","year":"2004","journal-title":"Chin. J. Neurosci."},{"issue":"9","key":"10.1016\/j.clineuro.2019.105587_bib0070","first-page":"735","article-title":"A study of plasma homocysteine in patients with Parkinson\u2019s disease and its clinical significance","volume":"5","author":"Yan","year":"2010","journal-title":"Chin. J. Stroke."},{"issue":"9","key":"10.1016\/j.clineuro.2019.105587_bib0075","first-page":"609","article-title":"Effect of L-dopa on plasma homocysteine in elderly patients with Parkinson\u2019s disease","volume":"39","author":"Wang","year":"2006","journal-title":"Chin. J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0080","first-page":"399","article-title":"Effect of levodopa on plasma homocysteine level in patients with parkinson\u2019s disease","volume":"27","author":"Li","year":"2014","journal-title":"J. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2019.105587_bib0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00702-011-0614-9","article-title":"Elevation of total homocysteine levels in patients with Parkinson\u2019s disease treated with duodenal levodopa\/carbidopa gel","volume":"118","author":"M\u00fcller","year":"2011","journal-title":"J. Neural. Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.clineuro.2019.105587_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2019.105587_bib0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: a systematic review","volume":"6","author":"Romagnolo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.clineuro.2019.105587_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2006.05.040","article-title":"Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson disease","volume":"404","author":"Religa","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.clineuro.2019.105587_bib0105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","article-title":"Homocysteine and cognitive impairment in Parkinson disease: a biochemical, neuroimaging, and genetic study","volume":"24","author":"Rodriguez-Oroz","year":"2009","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.clineuro.2019.105587_bib0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.clineuro.2019.105587_bib0115","first-page":"82","article-title":"The Rapid Community Cognitive screening programme (RAPCOG): developing the Portuguese version of the quick mild cognitive impairment (Qmci-P) screen as part of the EIP on AHA twinning scheme","volume":"19","author":"Machado Dos Santos","year":"2019","journal-title":"Transl. Med. UniSa"},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2019.105587_bib0125","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses","author":"Wells","year":"2009"},{"issue":"11","key":"10.1016\/j.clineuro.2019.105587_bib0130","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.clineuro.2019.105587_bib0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/1082-989X.6.3.203","article-title":"The power of statistical tests in meta-analysis","volume":"6","author":"Hedges","year":"2001","journal-title":"Psychol. Methods"},{"issue":"4","key":"10.1016\/j.clineuro.2019.105587_bib0150","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.clineuro.2019.105587_bib0155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clineuro.2019.105587_bib0160","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059421","article-title":"A meta-analysis of the association between TNF-alpha -308G& A polymorphism and type 2 diabetes mellitus in Han Chinese population","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clineuro.2019.105587_bib0170","first-page":"83","article-title":"Analysis on influence factors of hyperhomocysteinemia in patients with Parkinson\u2019s disease","volume":"17","author":"Yu","year":"2010","journal-title":"Stroke Nerv. Dis."},{"issue":"10","key":"10.1016\/j.clineuro.2019.105587_bib0175","first-page":"1188","article-title":"Effect of Madopar on homocysteine in patients with Parkinson\u2019s disease","volume":"8","author":"Ma","year":"2010","journal-title":"Chin. J. Integr. Med. Cardio-\/ Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0180","first-page":"545","article-title":"Correlational studies of serum homocysteine level and Parkinson\u2019s disease","volume":"6","author":"Peng","year":"2011","journal-title":"Int. Med. China"},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0185","first-page":"231","article-title":"Correlation between cognitive dysfunction and plasma homocysteine level in patients with Parkinson\u2019s disease","volume":"14","author":"Gan","year":"2012","journal-title":"Chin. J. Geriatr. Heart. Brain. Vessel. Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0190","first-page":"338","article-title":"Change of plasma levels of homocysteine, vitamin B12 and folic acid and the curative effect of B vitamins in patients with Parkinson disease","volume":"26","author":"Li","year":"2013","journal-title":"J. Clin. Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2019.105587_bib0195","first-page":"512","article-title":"Effects of entacapone on plasma homocysteine in Parkinson\u2019s disease patients on levodopa","volume":"93","author":"Zhao","year":"2013","journal-title":"Natl. Med. J. China"},{"key":"10.1016\/j.clineuro.2019.105587_bib0200","unstructured":"C.G. Zhang, Q.C. Zhang, J. Chen, Y.Y. Feng. Association of levodopa administration with hyperhomocysteinemia in patients with Parkinson\u2019s disease. (15) (2013), pp. 1435\u20131437. (Article in Chinese)."},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0205","first-page":"24","article-title":"Study of serum homocysteine level and Parkinson\u2019s disease","volume":"41","author":"Bao","year":"2014","journal-title":"China Pract. J. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0210","first-page":"624","article-title":"Correlation between plasma homocysteine levels and cognitive impairment in elderly Parkinson\u2019s patients","volume":"24","author":"Li","year":"2014","journal-title":"J. Hainan Med. Coll."},{"issue":"8","key":"10.1016\/j.clineuro.2019.105587_bib0215","first-page":"3","article-title":"Association between plasma homocysteine and cognitive dysfunction in patients with Parkinson\u2019s disease","volume":"12","author":"Cai","year":"2014","journal-title":"J. China Prescript. Drug"},{"issue":"9","key":"10.1016\/j.clineuro.2019.105587_bib0220","first-page":"78","article-title":"Clinical significance of plasma homocysteine detection in patients with Parkinson\u2019s disease","volume":"24","author":"Yang","year":"2015","journal-title":"China Pharm."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0225","first-page":"622","article-title":"Clinical significance of determination of plasma homocysteine in the treatment of Parkinson\u2019s disease with levodopa","volume":"13","author":"Zhang","year":"2015","journal-title":"J. Bethune Med. Sci."},{"key":"10.1016\/j.clineuro.2019.105587_bib0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2015.00247","article-title":"Contra-directional expression of serum homocysteine and uric acid as important biomarkers of multiple system atrophy severity: a cross-sectional study","volume":"9","author":"Chen","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.clineuro.2019.105587_bib0235","first-page":"153","article-title":"Discussion on the side-effect of levodopa on Parkinson\u2019s disease","author":"Ren","year":"2015","journal-title":"Health Vocat. Educ."},{"issue":"19","key":"10.1016\/j.clineuro.2019.105587_bib0240","first-page":"3660","article-title":"Study of serum homocysteine level and Parkinson\u2019s disease","volume":"15","author":"Zhang","year":"2015","journal-title":"Prog. Mod. Biomed."},{"issue":"10","key":"10.1016\/j.clineuro.2019.105587_bib0245","first-page":"1346","article-title":"The correlation between homocysteine and cognitive impairment in Parkinson\u2019s disease","volume":"45","author":"Li","year":"2016","journal-title":"Shaanxi Med. J."},{"issue":"7","key":"10.1016\/j.clineuro.2019.105587_bib0250","first-page":"631","article-title":"The changes and significance of plasma level of homocysteine in Parkinson disease patients with cognitive function","volume":"39","author":"Ye","year":"2016","journal-title":"Chin. J. Postgraduates Med."},{"issue":"11","key":"10.1016\/j.clineuro.2019.105587_bib0255","first-page":"109","article-title":"Effect of levodopa on plasma homocysteine level in elderly patients with Parkinson\u2019s disease","volume":"19","author":"Li","year":"2016","journal-title":"Chin. J. Pract. Nerv. Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0260","first-page":"949","article-title":"The correlation between plasma homocysteine level and cognitive impairment in elderly patients with Parkinson\u2019s disease","volume":"25","author":"Li","year":"2016","journal-title":"Henan Med. Res."},{"issue":"14","key":"10.1016\/j.clineuro.2019.105587_bib0265","first-page":"68","article-title":"Plasma homocysteine level and its relationship with Parkinson\u2019s disease","volume":"27","author":"Wang","year":"2017","journal-title":"China Health Care Nutr."},{"issue":"6","key":"10.1016\/j.clineuro.2019.105587_bib0270","first-page":"799","article-title":"Relationship between homocysteine level and cognitive function in elderly patients with parkinson\u2019s disease","volume":"29","author":"Ding","year":"2017","journal-title":"Mod. Pract. Med."},{"issue":"29","key":"10.1016\/j.clineuro.2019.105587_bib0275","first-page":"193","article-title":"Correlation between plasma homocysteine level and cognitive impairment in elderly patients with parkinson\u2019s disease","volume":"37","author":"Wu","year":"2018","journal-title":"China Fore. Med. Treat."},{"issue":"5","key":"10.1016\/j.clineuro.2019.105587_bib0280","first-page":"533","article-title":"Effect of dopa preparation on plasma homocysteine and uric acid in patients with Parkinson\u2019s disease","volume":"21","author":"Wang","year":"2018","journal-title":"Pract. Pharm. Clin. Remed."},{"issue":"22","key":"10.1016\/j.clineuro.2019.105587_bib0285","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2019.105587_bib0290","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7563705","article-title":"Homocysteine levels in parkinson\u2019s disease: is entacapone effective?","volume":"2016","author":"Kocer","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"9","key":"10.1016\/j.clineuro.2019.105587_bib0295","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000183063.99107.5c","article-title":"Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease","volume":"65","author":"Irizarry","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.clineuro.2019.105587_bib0300","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/1389202914666131210210559","article-title":"Homocysteine level and mechanisms of injury in parkinson\u2019s disease as related to MTHFR, MTR, and MTHFD1 genes polymorphisms and L-Dopa treatment","volume":"14","author":"Rozycka","year":"2013","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.clineuro.2019.105587_bib0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","article-title":"Levodopa and neuropathy risk in patients with Parkinson disease: effect of COMT inhibition","volume":"27","author":"Cossu","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"23","key":"10.1016\/j.clineuro.2019.105587_bib0310","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/sim.1091","article-title":"Approaches to heterogeneity in meta-analysis","volume":"20","author":"Petitti","year":"2001","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.clineuro.2019.105587_bib0315","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-009-9139-4","article-title":"Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson\u2019s disease","volume":"24","author":"dos Santos","year":"2009","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.clineuro.2019.105587_bib0320","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1471-4159.2001.00384.x","article-title":"Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress","volume":"78","author":"Ho","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.WNF.0000220817.94102.95","article-title":"The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status","volume":"29","author":"Zesiewicz","year":"2006","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.clineuro.2019.105587_bib0330","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson\u2019s disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.clineuro.2019.105587_bib0335","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS Task Force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.clineuro.2019.105587_bib0340","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2019.105587_bib0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ene.12567","article-title":"Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson\u2019s disease: the Barcelona-Lisbon cohort","volume":"22","author":"Coelho","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2019.105587_bib0350","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/nu9070725","article-title":"Plasma homocysteine and serum folate and vitamin B12 levels in mild cognitive impairment and Alzheimer\u2019s disease: a case-control study","volume":"9","author":"Ma","year":"2017","journal-title":"Nutrients"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671930383X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671930383X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:30:21Z","timestamp":1759588221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384671930383X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":70,"alternative-id":["S030384671930383X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2019.105587","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma homocysteine, folate and vitamin B12 levels in Parkinson\u2019s disease in China: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2019.105587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105587"}}